Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimab.
Shi Y, Su H, Song Y, Jiang W, Sun X, Qian W, Zhang W, Gao Y, Jin Z, Zhou J, Jin C, Zou L, Qiu L, Li W, Yang J, Hou M, Xiong Y, Zhou H, Du X, Wang X, Peng B.
Shi Y, et al. Among authors: jiang w.
EBioMedicine. 2020 Apr;54:102731. doi: 10.1016/j.ebiom.2020.102731.
EBioMedicine. 2020.
PMID: 32304999
Free PMC article.
Clinical Trial.